Zsolt Talloczy, PhD, is a Senior Director of Clinical Development at Novartis, specializing in global clinical development within neuroscience and immunology. They have extensive leadership experience in pre-clinical to clinical research, having led teams at Columbia University while authoring 18 scientific publications in prestigious journals. Talloczy's career includes significant contributions to the successful development and approval of multiple drugs, including Gilenya for multiple sclerosis and Cosentyx for dermatology and rheumatology. They hold a PhD in Microbiology and Molecular Genetics from Rutgers University and have participated in numerous international conferences as a speaker.
This person is not in the org chart
This person is not in any teams
This person is not in any offices